Novartis drug VotubiaR recommended by CHMP for EU approval to treat

Novartis drug VotubiaR suggested by CHMP for EU approval to treat
Everolimus is approved as Afinitor in 90 countries like the US and all through the EU in the adult oncology settings of advanced renal cell carcinoma following progression on or immediately after vascular endothelial growth aspect (VEGF)-targeted therapy in …
Read more on Reuters

Pfizer&#39s Cancer Drug Inlyta Receives European Approval
Pfizer&#39s (NYSE:PFE) Inlyta (axitinib) has received European Medicines Agency (EMA) approval, which implies the drug can now be prescribed for advanced renal cell carcinoma (RCC) as a second-line therapy in the European market. This news adds to the …
Read far more on Trefis

&#39Bling for a Result in&#39 brings hope and income for cancer study
In April 2010, Holly Freese watched as her best friend&#39s husband, 29, died 3 months immediately after becoming diagnosed with stage 4 renal cell carcinoma. &quotMy husband and I struggled with the thought of this and wanted to do one thing to help,&quot Freese says. &quotWe …